MENU
VIRX
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Viracta Therapeutics (VIRX) Ownership - Who owns Viracta Therapeutics?

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
437.19K
P/E Ratio
2.75
Total Cash
21.13M
Projected Growth
N/A
Total Debt
16.91M
Revenue
N/A
Risk (Beta)
0.13
Dividend Yield
N/A
Total Cash/Share
0.53
Total Debt/Equity
61.96
Revenue/Share
null USD as % of share price
Who owns Viracta Therapeutics? VIRX symbol Ownership - Tickeron.com